Trial
NCT05227209
A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sumitomo Pharma America, Inc.
Collaborators
—
Condition
Depressive Episodes, Bipolar I Depression
Intervention
SEP-4199 CR
Why stopped
Company decided not to move forward with further accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-21